Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and …
PD Riggs, T Winhusen, RD Davies… - Journal of the American …, 2011 - Elsevier
OBJECTIVE: To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and …
PD Riggs, T Winhusen, RD Davies… - Journal of the …, 2011 - europepmc.org
Objective To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with Attention-Deficit/Hyperactivity Disorder and …
PD Riggs, T Winhusen, RD Davies… - Journal of the …, 2011 - psycnet.apa.org
Objective: To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
Randomized Controlled Trial of Osmotic-Release Methylphenidate With Cognitive-Behavioral Therapy in Adolescents With Attention-Deficit/Hyperactivity Disorder and …
PD Riggs, T Winhusen, RD Davies… - Journal of the American …, 2011 - infona.pl
To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-MPH)
compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the impact on …
compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the impact on …
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and …
PD Riggs, T Winhusen… - Journal of the …, 2011 - utsouthwestern.elsevierpure.com
Objective: To evaluate the efficacy and safety of osmotic-release methylphenidate
(OROSMPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and …
(OROSMPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and …
Randomized Controlled Trial of Osmotic-Release Methylphenidate with Cognitive-Behavioral Therapy in Adolescents with Attention-Deficit/Hyperactivity Disorder and …
PD Riggs, T Winhusen, RD Davies… - Journal of the American …, 2011 - ERIC
Objective: To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
[引用][C] Randomized Controlled Trial of Osmotic-Release Methylphenidate With Cognitive-Behavioral Therapy in Adolescents With Aitention-Deficit/Hyperactivity …
PD RIGGS, T WINHUSEN, WB JAFFEE… - Journal of the …, 2011 - pascal-francis.inist.fr
Randomized Controlled Trial of Osmotic- Release Methylphenidate With Cognitive-
Behavioral Therapy in Adolescents With Aitention-Deficit/Hyperactivity Disorder and …
Behavioral Therapy in Adolescents With Aitention-Deficit/Hyperactivity Disorder and …
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and …
PD Riggs, T Winhusen, RD Davies, JD Leimberger… - 2011 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the …
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and …
PD Riggs, T Winhusen, RD Davies… - Journal of the …, 2011 - pure.johnshopkins.edu
Objective: To evaluate the efficacy and safety of osmotic-release methylphenidate
(OROSMPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and …
(OROSMPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and …